Course NURS-6630D-3/NURS-6630N-3/NURS-6630F-3-Approaches to
Treatment2018 Fall Quarter 08/27-11/18-PT27
Test Week 11 Final Exam
Started 11/10/18 1:37
PM Submitted 11/10/18 3:01
PM Due Date 11/12/18 1:59
AM
Status Completed
Attempt Score 72 out of 75
points
Time Elapsed 1 hour, 24 minutes out of 2 hours
Results Submitted Answers
Displaye
d
• Question 1
1 out of 1 points
What will the PMHNP most likely prescribe to a patient with psychotic aggression who needs to
manage the top-down cortical control and the excessive drive from striatal hyperactivity?
Selected Answer: C.
Antipsychotics
• Question 2
1 out of 1 points
The PMHNP is selecting a medication treatment option for a patient who is exhibiting psychotic
behaviors with poor impulse control and aggression. Of the available treatments, which can help
temper some of the adverse effects or symptoms that are normally caused by D2 antagonism?
Selected Answer: D.
,Second-generation, atypical antipsychotics
, • Question 3
1 out of 1 points
The PMHNP is discussing dopamine D2 receptor occupancy and its association with aggressive
behaviors in patients with the student. Why does the PMHNP prescribe a standard dose of atypical
antipsychotics?
Selected Answer: C.
The doses are based on achieving 60% D2 receptor occupancy.
• Question 4
1 out of 1 points
Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the patient
with psychosis and aggression?
Selected Answer: A.
There is too high a risk of serious adverse side effects.
• Question 5
1 out of 1 points
The PMHNP is caring for a patient on risperidone (Risperdal). Which action made by the PMHNP
exhibits proper care for this patient? </p?
Selected Answer: C.
Titrating the dose by increasing it every 5–7 days
• Question 6
1 out of 1 points
The PMHNP wants to prescribe Mr. Barber a mood stabilizer that will target aggressive and impulsive
symptoms by decreasing dopaminergic neurotransmission. Which mood stabilizer will the PMHNP
select?